Evidence map›Paper›PMID 40621631›Full record

ArticleCancer science2025

LATS1/2-Integrin Axis Confers Tumor-Generated Forces That Activate Neighboring Fibroblasts.

Yanliang Liu, Saisai Liu, Yasuhisa Sakamoto, Paweenapon Chunthaboon, Chanida Thinyakul, Ryunosuke Mori, Shuran Li, Takahiro Watanabe-Nakayama, Seiji Omata, Yasuyuki Morita and 1 more

Abstract read
In one paragraph

Article in Cancer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yanliang LiuDepartment of Molecular and Medical Pharmacology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Saisai LiuDepartment of Molecular and Medical Pharmacology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yasuhisa SakamotoDepartment of Molecular and Medical Pharmacology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Paweenapon ChunthaboonDepartment of Molecular and Medical Pharmacology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Chanida ThinyakulDepartment of Molecular and Medical Pharmacology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Ryunosuke MoriGraduate School of Science and Technology, Kumamoto University, Kumamoto, Japan.
Shuran LiDepartment of Molecular and Medical Pharmacology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Takahiro Watanabe-NakayamaWPI-Nano Life Science Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.
Seiji OmataFaculty of Advanced Science and Technology, Kumamoto University, Kumamoto, Japan.
Yasuyuki MoritaGraduate School of Science and Technology, Kumamoto University, Kumamoto, Japan.
Toshiro MoroishiDepartment of Molecular and Medical Pharmacology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0000-0001-6419-3882

Funding

Foundation for Promotion of Cancer Research in JapanHoansha FoundationIchiro Kanehara Foundation for the Promotion of Medical Sciences and Medical CareJapan Agency for Medical Research and Development JP22gm6210030Japan Science and Technology Agency JPMJFR226JJapan Society for the Promotion of Science 24H00864Japan Society for the Promotion of Science 24H00865Japan Society for the Promotion of Science 25K01123Kobayashi Foundation for Cancer ResearchMedical Research Center Initiative for High Depth OmicsMultilayered Stress Diseases JPMXP1323015483Nanken-KyotenPrincess Takamatsu Cancer Research FundTakeda Science Foundation
6 · The paper itself

Abstract

Tumors generate various forces during growth and progression, which in turn promote tumor development. Although fibroblasts are considered the primary force generators in the tumor microenvironment, recent studies have shown that cancer cells also generate considerable tensile forces. However, the roles that these forces play in the tumor microenvironment and the pathways regulating this process remain largely unknown. Here, we demonstrated that the Hippo pathway-associated kinases, LATS1/2, in cancer cells are essential for collective force generation and fibroblast activation via extracellular matrix-mediated cell-cell interactions. In murine breast cancer 4 T1 spheroids, the deletion of LATS1/2 dampened force generation and disrupted reorganization of the surrounding collagen matrix. LATS1/2-mediated mechanical forces of tumors are required for fibroblast activation and differentiation into mechanoresponsive fibroblasts. Mechanistically, LATS1/2 regulate tumor force generation through the expression of collagen receptor integrins. Our findings not only identify the Hippo pathway as a critical regulator of tumor force generation but also suggest potential strategies for targeting it in cancer therapy from a mechanobiological perspective, offering new avenues in the fight against cancer.

Indexed as

FibroblastsIntegrinsProtein Serine-Threonine KinasesTumor Suppressor ProteinsAnimalsCell CommunicationCell Line, TumorExtracellular MatrixFemaleHippo Signaling PathwayHumansMiceSignal TransductionTumor MicroenvironmentIntegrinsLATS1 protein, humanLats1 protein, mouseLATS2 protein, mouseProtein Serine-Threonine KinasesTumor Suppressor Proteinscancer‐associated fibroblasthippo pathwayintegrinsmechanobiologytumor microenvironment

Identifiers

PMID40621631
PMCPMC12400049

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.